- Citations, last 5 years
- 356.5k
- Works, last 5 years
- 25.4k
- h-index
- 1,797
- Scientists listed
- 655
- Grants since 2016
- 3 144
Grants received
2010–2028 · research · R01
Transcriptional control and enhancer recruitment in mouse and human intestinal secretory differentiation
Ramesh A Shivdasani · Dana-Farber Cancer Institute · funded by National Institutes of Health
2010–2028 · research · R01
Transcriptional control and enhancer recruitment in mouse and human intestinal secretory differentiation
Ramesh A Shivdasani · Dana-Farber Cancer Institute · funded by National Institutes of Health
2010–2026 · cooperative agreement · U54
2/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research
Gregory Alan Abel · Dana-Farber Cancer Institute · funded by National Institutes of Health
2010–2022 · research · R01
Regulation of intestinal genes by CDX2 and other tissue-restricted transcription factors
Ramesh A Shivdasani · Dana-Farber Cancer Institute · funded by National Institutes of Health
2010–2026 · cooperative agreement · U54
2/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research
Gregory Alan Abel · Dana-Farber Cancer Institute · funded by National Institutes of Health
2010–2021 · cooperative agreement · U54
2/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research
Gregory Alan Abel · Dana-Farber Cancer Institute · funded by National Institutes of Health
2010–2020 · research · R01
Molecular mechanism and relevance of microRNAs in DSB repair pathway choice
Dipanjan Chowdhury · Dana-Farber Cancer Institute · funded by National Institutes of Health
2010–2021 · research · R01
Molecular mechanism and relevance of microRNAs in DSB repair pathway choice
Dipanjan Chowdhury · Dana-Farber Cancer Institute · funded by National Institutes of Health
2010–2020 · research · R01
Overcoming bias and unwanted variability in next generation sequencing
Rafael Angel Irizarry · Dana-Farber Cancer Institute · funded by National Institutes of Health
2010–2026 · cooperative agreement · U54
2/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research
Gregory Alan Abel · Dana-Farber Cancer Institute · funded by National Institutes of Health
2010–2026 · cooperative agreement · U54
Advancing research methods to better understand health literacy and health equity in digital communications
Gregory Alan Abel · Dana-Farber Cancer Institute · funded by National Institutes of Health
2010–2021 · research · R01
CRLF2 signaling in B-cell acute lymphoblastic leukemia
David Marc Weinstock · Dana-Farber Cancer Institute · funded by National Institutes of Health
2010–2022 · research · R01
Regulation of intestinal genes by CDX2 and other tissue-restricted transcription factors
Ramesh A Shivdasani · Dana-Farber Cancer Institute · funded by National Institutes of Health
2010–2021 · cooperative agreement · U54
2/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research
Gregory Alan Abel · Dana-Farber Cancer Institute · funded by National Institutes of Health
2010–2021 · cooperative agreement · U54
2/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research
Gregory Alan Abel · Dana-Farber Cancer Institute · funded by National Institutes of Health
2010–2021 · cooperative agreement · U54
2/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research
Kasisomayajula Viswanath · Dana-Farber Cancer Institute · funded by National Institutes of Health
2010–2026 · cooperative agreement · U54
2/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research
Gregory Alan Abel · Dana-Farber Cancer Institute · funded by National Institutes of Health
2010–2026 · cooperative agreement · U54
2/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research
Gregory Alan Abel · Dana-Farber Cancer Institute · funded by National Institutes of Health
2010–2028 · research · R01
Transcriptional control and enhancer recruitment in mouse and human intestinal secretory differentiation
Ramesh A Shivdasani · Dana-Farber Cancer Institute · funded by National Institutes of Health
2010–2026 · cooperative agreement · U54
Testing Homebased ExeRcise Strategies to Improve Exercise Participation and CardioVascular Health in UndersErved Minority Patients with Cancer Undergoing Chemotherapy, the THRIVE Study
Christina Dieli-Conwright · Dana-Farber Cancer Institute · funded by National Institutes of Health
2010–2021 · cooperative agreement · U54
Administrative Core
Kasisomayajula Viswanath · Dana-Farber Cancer Institute · funded by National Institutes of Health
2010–2026 · cooperative agreement · U54
Shared Resource Core
Wendy Beth London · Dana-Farber Cancer Institute · funded by National Institutes of Health
2010–2026 · cooperative agreement · U54
Administrative Core
Kasisomayajula Viswanath · Dana-Farber Cancer Institute · funded by National Institutes of Health
2010–2026 · cooperative agreement · U54
High Frequency of CHD1 Loss in BRCA2- Deficient African American Prostate Tumors Drives Tumor Formation by Suppressing Replication Stress
Zoltan Szallasi · Dana-Farber Cancer Institute · funded by National Institutes of Health
2010–2026 · cooperative agreement · U54
Planning and Evaluation Core
Kasisomayajula Viswanath · Dana-Farber Cancer Institute · funded by National Institutes of Health
2010–2026 · cooperative agreement · U54
Planning and Evaluation Core
Kasisomayajula Viswanath · Dana-Farber Cancer Institute · funded by National Institutes of Health
2010–2026 · cooperative agreement · U54
Genomics Core
Nikhil Wagle · Dana-Farber Cancer Institute · funded by National Institutes of Health
2010–2026 · cooperative agreement · U54
Outreach Core
Shoba Ramanadhan · Dana-Farber Cancer Institute · funded by National Institutes of Health
2010–2026 · cooperative agreement · U54
Administrative Core
Kasisomayajula Viswanath · Dana-Farber Cancer Institute · funded by National Institutes of Health
2010–2026 · cooperative agreement · U54
Targeting androgen receptor signaling in prostate cancer in men with African ancestry
Steven P. Balk · Dana-Farber Cancer Institute · funded by National Institutes of Health
2010–2026 · cooperative agreement · U54
Genomics Core
Nikhil Wagle · Dana-Farber Cancer Institute · funded by National Institutes of Health
2010–2026 · cooperative agreement · U54
Research Education Core
Karen Ann Burns White · Dana-Farber Cancer Institute · funded by National Institutes of Health
2010–2026 · cooperative agreement · U54
Shared Resource Core
Wendy Beth London · Dana-Farber Cancer Institute · funded by National Institutes of Health
2010–2026 · cooperative agreement · U54
Targeting androgen receptor signaling in prostate cancer in men with African ancestry
Steven P. Balk · Dana-Farber Cancer Institute · funded by National Institutes of Health
2010–2021 · cooperative agreement · U54
Research Education Core
Karen Ann Burns White · Dana-Farber Cancer Institute · funded by National Institutes of Health
2010–2021 · cooperative agreement · U54
Outreach Core
Shoba Ramanadhan · Dana-Farber Cancer Institute · funded by National Institutes of Health
2010–2021 · cooperative agreement · U54
Shared Resource Core
Wendy Beth London · Dana-Farber Cancer Institute · funded by National Institutes of Health
2010–2021 · cooperative agreement · U54
Planning and Evaluation Core
Kasisomayajula Viswanath · Dana-Farber Cancer Institute · funded by National Institutes of Health
2010–2026 · cooperative agreement · U54
Research Education Core
Karen Ann Burns White · Dana-Farber Cancer Institute · funded by National Institutes of Health
2010–2026 · cooperative agreement · U54
Impact of changing restaurant advertising on weight gain and disparities
Briana Joy Kennedy Stephenson · Dana-Farber Cancer Institute · funded by National Institutes of Health
